Skip to main content


Page 2 of 14

  1. Extracorporeal membrane oxygenation (ECMO) can provide life-saving support for critically ill patients suffering severe respiratory and/or cardiac failure. However, thrombosis and bleeding remain common and co...

    Authors: Saeedreza Zeibi Shirejini, Josie Carberry, Zoe K. McQuilten, Aidan J. C. Burrell, Shaun D. Gregory and Christoph E. Hagemeyer
    Citation: Thrombosis Journal 2023 21:11
  2. Tranexamic acid (TXA) is an antifibrinolytic drug that blocks lysine-binding sites on the profibrinolytic enzyme plasminogen. Aortic diseases with chronic consumption coagulopathy may lead to disseminated intr...

    Authors: Naruko Suzuki, Nobuaki Suzuki, Yuka Kawaguchi, Shuichi Okamoto, Takeshi Kanematsu, Akira Katsumi, Atsuo Suzuki, Shogo Tamura, Tetsuhito Kojima, Hitoshi Kiyoi and Tadashi Matsushita
    Citation: Thrombosis Journal 2023 21:10
  3. Portal vein thrombosis is a common complication of liver cirrhosis and hepatocellular carcinoma; however, few studies have reported its long-term clinical prognosis. This study aimed to establish and validate ...

    Authors: Xuan Zhong, Shan Li, Jiali Hu, Jinlai Lu, Wei Wang, Miao Hu, Qinjuan Sun, Shuo Zhang, Xiaoqing Yang, Changqing Yang and Lan Zhong
    Citation: Thrombosis Journal 2023 21:9
  4. The assessment of VTE likelihood with VTE risk scores is essential prior to imaging examinations during VTE diagnostic procedure. Little is known with respect to the disparity of predictive power for VTE diagn...

    Authors: Wei Xiong, Yunfeng Zhao, Yi Cheng, He Du, Jinyuan Sun, Yanmin Wang, Mei Xu and Xuejun Guo
    Citation: Thrombosis Journal 2023 21:8
  5. Several prior studies postulated an effect of hypertension on coagulation factors. However, population-based studies investigating the sex-specific associations between hypertension and hemostatic parameters a...

    Authors: J. Vogel von Falckenstein, D. Freuer, A. Peters, M. Heier, J. Linseisen and C. Meisinger
    Citation: Thrombosis Journal 2023 21:7
  6. Cavernous transformation of the portal vein (CTPV) in cirrhotic patients with extrahepatic portal vein obstruction (EHPVO) was a relatively rare disease and had no consensus on the treatment. Our study aimed t...

    Authors: Yongjie Zhou, Zhiquan Zhuang, Tianzhu Yu, Wen Zhang, Jingqin Ma, Jiaze Yu, Zhiping Yan and Jianjun Luo
    Citation: Thrombosis Journal 2023 21:6
  7. Patients with peripheral artery disease (PAD) are treated with preventive strategies to improve the cardiovascular risk. The incidence of cardiovascular events and mortality however remains high in PAD populat...

    Authors: B. M. M. Kremers, J. H. C. Daemen, H. ten Cate, H. M. H. Spronk, B. M. E. Mees and A. J. ten Cate-Hoek
    Citation: Thrombosis Journal 2023 21:5
  8. Extracorporeal membrane oxygenation (ECMO) is applied in patients with respiratory or cardiopulmonary failure, but bleeding is a frequent complication contributing to the high mortality rates in this patient c...

    Authors: Martin Büchsel, Ulrich Geisen, Clara Beckenkamp, Tobias Wengenmayer, Barbara Zieger, Dirk Westermann and Patrick M. Siegel
    Citation: Thrombosis Journal 2023 21:4
  9. Antithrombin (AT) is the main physiological anticoagulant involved in hemostasis. Hereditary AT deficiency is a rare autosomal dominant thrombotic disease mainly caused by mutations in SERPINC1, which was usually...

    Authors: Han-lu Wang, Dan-dan Ruan, Min Wu, Yuan-yuan Ji, Xing-xing Hu, Qiu-yan Wu, Yan-ping Zhang, Bin Lin, Ya-nan Hu, Hang Wang, Yi Tang, Zhu-ting Fang, Jie-wei Luo, Li-sheng Liao and Mei-zhu Gao
    Citation: Thrombosis Journal 2023 21:3
  10. Fusobacterium nucleatum (F. nucleatum) often colonizes cancerous gastric tissues and is characterized by the promotion of platelet aggregation and the development of visceral thrombosis. Venous thromboembolism (V...

    Authors: Chang Liu, Zhou Yang, Xiance Tang, Fangfang Zhao, Mengke He, Changpeng Liu, Dongmin Zhou, Lifeng Wang, Bo Gu, Yiqiang Yuan and Xiaobing Chen
    Citation: Thrombosis Journal 2023 21:2
  11. (p-BthTX-I)2 K, a dimeric analog peptide derived from the C-terminal region of phospholipase A2-like bothropstoxin-I (p-BthTX-I), is resistant to plasma proteolysis and inhibits severe acute respiratory syndrome ...

    Authors: Ruben Siedlarczyk Nogueira, Bruno Ramos Salu, Vinícius Goulart Nardelli, Camila Ramalho Bonturi, Marina Rodrigues Pereira, Francisco Humberto de Abreu Maffei, Eduardo Maffud Cilli and Maria Luiza Vilela Oliva
    Citation: Thrombosis Journal 2023 21:1
  12. The prognostic implication of liver fibrosis in acute coronary syndrome (ACS) patients are scarce. We sought to evaluate whether liver fibrosis scores (LFS) were associated with thrombotic or bleeding events i...

    Authors: Yupeng Liu, Jingjing Song, Wenyao Wang, Kuo Zhang, Jie Yang, Jun Wen, Xiangbin Meng, Jun Gao, Jingjia Wang, Chunli Shao and Yi-Da Tang
    Citation: Thrombosis Journal 2022 20:82
  13. Mutations in SERPINC1 lead to deficiency in antithrombin (AT) which is an endogenous anticoagulant of normal hemostasis and could result in venous thromboembolism (VTE).

    Authors: Teng Huang, Yu Liu, Xiaofeng Jiang, Wei Zhang, Honglian Zhou and Qi Hu
    Citation: Thrombosis Journal 2022 20:81
  14. Postoperative pulmonary embolism (PE) is a severe complication leading to death and poor prognosis. The present study investigated the risk factors and potential predictors of PE in cancer patients undergoing ...

    Authors: Yi Li, Zhenjun Liu, Chen Chen, Dan Li, Huan Peng, Pei Zhao and Jiuhui Wang
    Citation: Thrombosis Journal 2022 20:80
  15. Tranexamic acid (TXA) plays a significant role in the treatment of traumatic diseases. However, its effectiveness in patients with traumatic brain injury (TBI) seems to be contradictory, according to the recen...

    Authors: Honghao Huang, Mei Xin, Xiqiang Wu, Jian Liu, Wenxin Zhang, Ke Yang and Jinbao Zhang
    Citation: Thrombosis Journal 2022 20:79
  16. To assess the immediate effect and factors affecting the efficacy of rotational thrombectomy (RT) in patients with thrombus-containing lower-limb ischaemic lesions.

    Authors: Jinyan Xu, Qingyuan Yu, Guanglang Zhu, Zhiqing Zhao, Yu Xiao, Junmin Bao and Liangxi Yuan
    Citation: Thrombosis Journal 2022 20:78
  17. Thromboembolism was a chief cause of mortality in 70% of patients with COVID-19. Our objective was to see if serum interleukins 1 beta (IL-1β) and soluble platelets selectin (sP-selectin) could serve as novel ...

    Authors: Sara El-Sayed Abd El-Ghani, Reham Mohammad Raafat Hamed, Ragaey Ahmad Eid, Ahmed Yassin Mohammed Ibrahim, Hoda M. Abdel-Hamid, Walaa Abdelrahman, Raghda Ebaid Ibrahim, Manar Mahmoud Abdel-Aziz and Marwa Salah Mohamed
    Citation: Thrombosis Journal 2022 20:77
  18. Thromboelastometry is considered the best method to assesses hemostasis in liver disease. Diagnostic performance could be improved by adding protein C activators such as thrombomodulin or Protac®.

    Authors: Andrea Calvo, Miguel Angel Torrente, Klaus Görlinger, Javier Fernandez, Enric Reverter, Julia Vidal, Dolors Tassies, Jordi Colmenero, Annabel Blasi and Juan Carlos Reverter
    Citation: Thrombosis Journal 2022 20:75
  19. Critically ill patients in intensive care units (ICUs) are at high risk of venous thromboembolism (VTE). This study aimed to explore the prophylaxis effect under a guideline-based thromboprophylaxis protocol a...

    Authors: Xiao Tang, Wen-Rui Lyu, Yu Jin, Rui Wang, Xu-Yan Li, Ying Li, Chun-Yan Zhang, Wei Zhao, Zhao-Hui Tong and Bing Sun
    Citation: Thrombosis Journal 2022 20:76
  20. Thrombotic events are common in critically ill patients with COVID-19 and have been linked with COVID-19- induced hyperinflammatory state. In addition to anticoagulant effects, heparin and its derivatives have...

    Authors: Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Awatif Hafiz, Mai Alalawi, Hisham A. Badreldin, Ali F. Altebainawi, Ramesh Vishwakarma, Abdulrahman Alissa, Albandari Alghamdi, Abeer A. Alenazi, Huda Al Enazi, Shahad Alanazi, Abdullah Alhammad, Jahad Alghamdi, Mashael AlFaifi…
    Citation: Thrombosis Journal 2022 20:74
  21. Acutely ill medical patients experience deep venous thrombosis (DVT) during the hospitalization, however the time course of DVT is still unclear.

    Authors: Lorenzo Loffredo, Gianpaolo Vidili, Angela Sciacqua, Chiara Cogliati, Rosella Di Giulio, Sciaila Bernardini, Paolo Ciacci, Antonello Pietrangelo, Federica Orlando, Aurora Paraninfi, Maria Boddi, Giovanni Di Minno, Lorenzo Falsetti, Corrado Lodigiani, Angelo Santoliquido, Evaristo Ettorre…
    Citation: Thrombosis Journal 2022 20:72
  22. Patients with end-stage kidney disease on haemodialysis suffer from frequent complications requiring hospitalisation. Atrial fibrillation is a burdensome comorbidity amongst patients on haemodialysis. We aimed...

    Authors: Daniel Steiner, Sabine Schmaldienst, Matthias Lorenz, Renate Klauser-Braun, Ingrid Pabinger, Cihan Ay, Marcus Säemann and Oliver Königsbrügge
    Citation: Thrombosis Journal 2022 20:71
  23. Thrombotic complications are synergistic and associated with orthopedic procedures, trauma, and malignancy. Because cancer enhances coagulation activity and vice versa, we assessed preoperative biomarkers for ...

    Authors: Sanna Matilainen, Gilber Kask, Jyrki Nieminen, Riitta Lassila and Minna Laitinen
    Citation: Thrombosis Journal 2022 20:70
  24. It is well established that lipoprotein(a)[Lp(a)] play a vital role in atherosclerosis. Whether Lp(a) can predict recurrence of cardiovascular events (CVEs) in prior CVEs patients is still unclear. We aim to i...

    Authors: Na Xu, Yi Yao, Lin Jiang, Jingjing Xu, Huanhuan Wang, Ying Song, Yuejin Yang, Bo Xu, Runlin Gao and Jinqing Yuan
    Citation: Thrombosis Journal 2022 20:69
  25. Venous thromboembolism (VTE) is a life-threatening cardiovascular syndrome that characterized by the imbalance of hemostasis and thrombosis and the formation of thrombi in the blood vessels. The aim of this st...

    Authors: Ziran Wang, Lingjun Kong, Guoju Luo, Han Zhang, Fengchun Sun, Wenjuan Liang, Wei Wu, Zijian Guo, Rui Zhang and Yaling Dou
    Citation: Thrombosis Journal 2022 20:68
  26. The relationship between vascular endothelial growth factor (VEGF) and the risk of venous thromboembolism (VTE) has always been one of the concerns in the medical field. However, the causal inferences from pub...

    Authors: Qiaoyun Zhang, Xiaoyu Zhang, Jie Zhang, Biyan Wang, Qiuyue Tian, Xiaoni Meng, Jinxia Zhang, Mengyang Jiang, Yiqiang Zhang, Deqiang Zheng, Lijuan Wu, Wei Wang, Baoguo Wang and Youxin Wang
    Citation: Thrombosis Journal 2022 20:67
  27. This study aimed to evaluate the efficacy and safety of oral anticoagulants (OACs) in real-world elderly patients with comorbidities of stable coronary artery disease (SCAD) and atrial fibrillation (AF).

    Authors: Xu Zhang, Yangxun Wu, Chao Lv, Shizhao Zhang, Haiping Liu, Yuyan Wang, Yuting Zou, Liu’an Qin, Junmeng Zhang and Tong Yin
    Citation: Thrombosis Journal 2022 20:66
  28. Warfarin is the most widely used oral anticoagulant; nevertheless, dosing of warfarin is problematic for clinicians worldwide. Inter-individual variability in response to warfarin is attributed to genetic as w...

    Authors: Weam Aldiban, Yara Altawil, Samir Hussein, Majd Aljamali and Lama A. Youssef
    Citation: Thrombosis Journal 2022 20:65
  29. Vitamin K antagonists and different direct oral anticoagulants (DOACs) have different renal clearance rates. However, the impact of different stages of chronic renal impairment on the efficacy and safety of wa...

    Authors: Wei-Chieh Lee, Ting-Wei Liao, Hsiu-Yu Fang, Po-Jui Wu, Yen-Nan Fang, Huang-Chung Chen, Yu-Sheng Lin, Shang-Hung Chang, Ping-Yen Liu and Mien-Cheng Chen
    Citation: Thrombosis Journal 2022 20:64
  30. Neutrophil extracellular traps (NETs) may be associated with the development of thrombosis. Experimental studies have confirmed the presence of NETs in thrombi specimens and potential role of NETs in the mecha...

    Authors: Xiangbo Xu, Yuting Wu, Shixue Xu, Yue Yin, Walter Ageno, Valerio De Stefano, Qingchun Zhao and Xingshun Qi
    Citation: Thrombosis Journal 2022 20:63
  31. To estimate the incidence, risk factors, and impact on mortality and functional outcomes for early coagulopathy after the return of spontaneous circulation (ROSC) in pediatric out-of-hospital cardiac arrest (O...

    Authors: Dawei Zhou, Tong Li, Yi Lv, Dijia Wang, Rongli Zhang, Qing Lin, Chao Wang, Dong Zhao, Shuyang Fei and Wei He
    Citation: Thrombosis Journal 2022 20:62
  32. Coronavirus disease 2019 (COVID-19) has spread worldwide. Vaccination is now recommended as one of the effective countermeasures to control the pandemic or prevent the worsening of symptoms. However, its adver...

    Authors: Ryo Kaimori, Haruto Nishida, Tomohisa Uchida, Mari Tamura, Kohji Kuroki, Kumi Murata, Kinta Hatakeyama, Yoshihiko Ikeda, Kisaki Amemiya, Akira Nishizono, Tsutomu Daa and Shinjiro Mori
    Citation: Thrombosis Journal 2022 20:61
  33. During pregnancy and puerperium women are at high VTE risk. Current guidelines recommend dynamic VTE-risk assessment during pregnancy. Based on related RCOG-guidelines we constructed a digital VTE-risk assessm...

    Authors: Elisavet Grouzi, Abraham Pouliakis, Αnthi Aktypi, Anna Christoforidou, Paraskevi Kotsi, Georgios Αnagnostou, Aikaterini Foifa and Emmanouil Papadakis
    Citation: Thrombosis Journal 2022 20:60
  34. Rectus sheath hematoma (RSH) is a relatively uncommon cause of acute abdominal pain and can be mistaken as other surgical causes of acute abdomen. A diagnosis requires high index of suspicion especially in sus...

    Authors: Cheuk-Lik Wong and Clarence Hao-Yu So
    Citation: Thrombosis Journal 2022 20:59
  35. Oral anticoagulation therapy with warfarin requires frequent monitoring level of anticoagulation by the international normalized ratio (INR). In Africa, studies that explore anticoagulation control, treatment ...

    Authors: Tamrat Assefa Tadesse, Gobezie Temesgen Tegegne, Dejuma Yadeta, Legese Chelkaba and Teferi Gedif Fenta
    Citation: Thrombosis Journal 2022 20:58
  36. Portomesenteric Vein Thrombosis (PMVT) following Laparoscopic Sleeve Gastrectomy (LSG) is an uncommon but potentially debilitating complication. Catheter-Directed Thrombolysis (CDT) has an evolving role in rec...

    Authors: Ali Barah, Israa Al-Hashimi, Rahil Kassamali, Qayed Aldebyani, Omran Almokdad, Ayman Elmagdoub, Mohammed Khader, Saad U. Rehman and Ahmed Omar
    Citation: Thrombosis Journal 2022 20:57
  37. According to several studies, ROS1 rearrangement is associated with thrombotic risk in non-small cell lung cancer (NSCLC). However, there is no clear understanding of the predictors and prognostic impact of th...

    Authors: Jiawen Yi, Huang Chen, Jie Li, Xingran Jiang, Yan Xu, Mengzhao Wang, Zheng Wang, Zhenguo Zhai, Yanhong Ren and Yuhui Zhang
    Citation: Thrombosis Journal 2022 20:56
  38. In Covid-19, anticoagulation with heparin is often administered to prevent or treat thromboembolic events. Heparin-induced thrombocytopenia (HIT) is a severe complication of heparin treatment, caused by hepari...

    Authors: Dominik F. Draxler, Justine Brodard, Björn Zante, Stephan M. Jakob, Jan Wiegand, Johanna A. Kremer Hovinga, Anne Angelillo-Scherrer and Alicia Rovo
    Citation: Thrombosis Journal 2022 20:55
  39. Long non-coding RNA (lncRNA) essentially controls many physiological and pathological processes of deep vein thrombosis (DVT). Based on that, lncRNA taurine upregulated gene 1 (TUG1)-involved angiogenesis of e...

    Authors: Yaping Feng, Bo Lei, Huan Zhang, Luyuan Niu, Xiangtao Li, Xiaoyun Luo and Fuxian Zhang
    Citation: Thrombosis Journal 2022 20:54
  40. The coronavirus disease 2019 (COVID-19) causes extensive coagulopathy and a potential benefit of anticoagulation therapy has been documented for prevention of thromboembolic events. Bleeding events has also be...

    Authors: Junichi Nakamura, Ichizo Tsujino, Sen Yachi, Makoto Takeyama, Yuji Nishimoto, Satoshi Konno, Naoto Yamamoto, Hiroko Nakata, Satoshi Ikeda, Michihisa Umetsu, Shizu Aikawa, Hiroya Hayashi, Hirono Satokawa, Yoshinori Okuno, Eriko Iwata, Yoshito Ogihara…
    Citation: Thrombosis Journal 2022 20:53
  41. Isolated distal deep vein thrombosis (IDDVT), a disease frequently detected in hospitalized patients, can progress to proximal deep vein thrombosis (PDVT) and pulmonary embolism (PE). Here, we evaluated the ef...

    Authors: Xiaolin Luo, Liying Zhang, Changchun Hou, Pengda Li, Shaofa Wu, Zebi Wang, Enpu Yang, Yun Cui, Ning Sun, Yang Yu, Zhixia An, Jun Jin and Zhexue Qin
    Citation: Thrombosis Journal 2022 20:52
  42. This study aims to provide 14-year nationwide epidemiology data to evaluate the incidence ratio of APS in Taiwan and the condition of comorbidities by analyzing the National Health Insurance Research Database.

    Authors: Wei-Cheng Yao, Kam-Hang Leong, Lu-Ting Chiu, Po-Yi Chou, Li-Chih Wu, Chih-Yu Chou, Chien-Feng Kuo and Shin-Yi Tsai
    Citation: Thrombosis Journal 2022 20:50
  43. Authors: Hirotaka Mori, Yuki Kataoka, Kayo Harada-Shirado, Noriaki Kawano, Mineji Hayakawa, Yoshinobu Seki, Toshimasa Uchiyama, Kazuma Yamakawa, Hiroyasu Ishikura, Yuhei Irie, Kenji Nishio, Noritaka Yada, Kohji Okamoto, Shingo Yamada and Takayuki Ikezoe
    Citation: Thrombosis Journal 2022 20:49

    The original article was published in Thrombosis Journal 2022 20:33

  44. SARS-CoV-2 infections are suspected to trigger the coagulation system through various pathways leading to a high incidence of thromboembolic complications, hypercoagulation and impaired fibrinolytic capacity w...

    Authors: Lars Heubner, Marvin Greiner, Oliver Vicent, Jan Beyer-Westendorf, Oliver Tiebel, Ute Scholz, Andreas Güldner, Martin Mirus, Dietmar Fries, Thea Koch and Peter Markus Spieth
    Citation: Thrombosis Journal 2022 20:48
  45. Thrombosis in patients with thrombocytopenia has several risk factors, both disease-related and treatment-associated. Recently, COVID-19 infection was recognized as an additional risk factor, further complicat...

    Authors: Alessandro Bosi, Wilma Barcellini and Bruno Fattizzo
    Citation: Thrombosis Journal 2022 20:46

    The Correction to this article has been published in Thrombosis Journal 2022 20:51

  46. Previous studies demonstrate a reduced risk of thrombosis and mortality with anticoagulant treatment in patients with COVID-19 than in those without anticoagulation treatment. However, an open question regardi...

    Authors: Hong Duo, Yahui Li, Yujie Sun, Liang Wei, Ziqing Wang, Fang Fang, Yuxin Zhong, Jiao Huang, Linjie Luo, Zhiyong Peng and Huaqin Pan
    Citation: Thrombosis Journal 2022 20:47
  47. Some conventional vaccines have been recognized as a cause of secondary immune thrombocytopenia (ITP). According to recent publications, mRNA vaccines are probably associated with an increased risk of ITP.

    Authors: Marc Weiner, Robert Rodriguez-Vigouroux, Stavroula Masouridi-Levrat and Kaveh Samii
    Citation: Thrombosis Journal 2022 20:45
  48. Cardiovascular diseases are the leading cause of death worldwide. Ticagrelor is an oral antiplatelet drug used in acute coronary syndrome. Although generic drugs are approved for their bioequivalence to the or...

    Authors: Bassem Zarif, Lamyaa Soliman, Nirmeen A. Sabry and Eman Said
    Citation: Thrombosis Journal 2022 20:44

Official journal of

  • Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.

    Members of APSTH are entitled to a 15% discount on the article processing charge.

Annual Journal Metrics